20/20 Biolabs, Inc. (AIDX)
NASDAQ · Healthcare
20/20 Biolabs, Inc. Shareholder Equity 2024–2025
20/20 Biolabs, Inc. annual shareholder equity history from 2024 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- 20/20 Biolabs, Inc. shareholder equity as of December 31, 2025: -19,225, a 101.28% decrease year-over-year.
- 20/20 Biolabs, Inc. shareholder equity for 2025 were -19,225, a 101.28% decrease from 2024.
- 20/20 Biolabs, Inc. shareholder equity for 2024 were 1.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| 20/20 Biolabs, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-0 |
| 2024 | $2 |
20/20 Biolabs, Inc. Shareholder Equity — FAQ
20/20 Biolabs, Inc. (AIDX) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AIDX's shareholder equity history?
The chart and table above show 20/20 Biolabs, Inc.'s shareholder equity by year and by quarter, including the growth rate.